AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Year-over-year operating income growth rate
Latest
7.21%
↑ 157% vs avg
Percentile
P79
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-12.75%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 7.21% |
| Q3 2025 | -39.14% |
| Q2 2025 | 37.45% |
| Q1 2025 | -34.18% |
| Q4 2024 | 38.65% |
| Q3 2024 | 11.75% |
| Q2 2024 | 13.21% |
| Q1 2024 | 2.76% |
| Q4 2023 | -3.49% |
| Q3 2023 | -9.51% |
| Q2 2023 | -3.50% |
| Q1 2023 | -28.56% |
| Q4 2022 | -6.00% |
| Q3 2022 | -13.91% |
| Q2 2022 | -34.49% |
| Q1 2022 | -1.17% |
| Q4 2021 | -9.55% |
| Q3 2021 | -38.70% |
| Q2 2021 | -143.80% |
| Q1 2021 | 0.00% |